It is reported that in more than 70% of WHO grade 2/3 cases and secondary astrocytoma, grade 4, carry a heterozygous missense mutation at the IDH1 codon 132, the substitution of Arg132 with histidine (IDH1-R132H). The gene discussed is IDH1; the disease is astrocytoma (excluding glioblastoma).